Is Maat Pharma SA halal to invest in?

According to Musaffa's Shariah screening methodology, Maat Pharma SA (MAAT.PA) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Maat Pharma SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Maat Pharma SA using these criteria to determine its compliance status.

Can Muslims buy shares of Maat Pharma SA?

Muslim investors may consider investing in Maat Pharma SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Maat Pharma SA classified as HALAL?

Musaffa determines the Shariah status of Maat Pharma SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Maat Pharma SA updated?

The Shariah compliance status of Maat Pharma SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Maat Pharma SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Maat Pharma SA?

You can check the latest Shariah compliance status of Maat Pharma SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Maat Pharma SA MAAT.PA

€7.24 €0.05 (0.70%) 1D

Last Updated: May 15, 12:00 AM·XPAR

MAAT.PA Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 05, 2026

Report Source: 2025 2nd Quarter Report

Maat Pharma SA. Stock Analysis MAAT.PA

France Health Care Micro Cap Report: Q2, 2025

Maat Pharma SA operates as a clinical-stage microbiome therapeutics company. The company employs 55 full-time employees The company went IPO on 2021-11-08. The firm specializes in the microbiome therapy that is aimed to treatment of Gut Microbiota alteration (Dysbiosis) using patient-specific biotherapeutics in patients with serious medical conditions. Its MaaT Microbiome Restoration Therapy (MMRB) discovery and analysis platform supports the evaluation of drug candidates, the determination of new disease targets and the identification of biomarkers for microbiome-related conditions.

Key Statistics of Maat Pharma SA (MAAT.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€7.10€7.24

Today's Open

€7.19

Volume

2251.00

P/E Ratio (TTM)

52 Week Range

€3.55€8.62

Market Cap

110.69M

Avg. Volume

10.18K

Dividend Yield

Financial Metrics & Statements of Maat Pharma SA (MAAT.PA)

FAQ's for Maat Pharma SA (MAAT.PA)

According to Musaffa’s Shariah screening methodology, Maat Pharma SA (MAAT.PA) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.